When was Cerus founded?

Cerus was founded in 1991 and raised its 1st funding round 10 years after it was founded.

Where is Cerus located?

Cerus is headquartered in Concord, United States. It is registered at Concord, California.

How many employees does Cerus have?

As of Sep 30, 2026, the latest employee count at Cerus is 382.

Is Cerus a funded company?

Cerus is a funded company, having raised an undisclosed amount across 6 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on May 18, 2001.

When was the latest funding round of Cerus?

Cerus' latest funding was a $***** Grant (prize money) round on Feb 18, 2020, with participation from 1 investor.

What is the annual revenue of Cerus?

Annual revenue of Cerus is between $100M and $500M as on Dec 31, 2025

Where does Cerus rank among its competitors?

Cerus ranks 3rd amongst 31 active competitors, of which 8 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Amferia, which secured $4.11M in Dec, 2025.

Who are the top competitors of Cerus?

Cerus' top competitors include Aethlon Medical, Amferia and Cel-Sci. Among them, Amferia secured the most recent funding round in December, 2025.

Cerus - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Provider of pathogen inactivation technology for blood center or hospital blood bank. The company's product "INTERCEPT system" allows high throughput processing of platelets and plasma from whole blood and apheresis collections. The device uses amotosalen-based pathogen inactivation technology to ensure reduced risk of transfusion-transmitted diseases by inactivating a variety of pathogens such as viruses, bacteria, and parasites.

Website: www.cerus.com/
Social
Phone Number: +1 **********
Registered Address: Concord, California

Key Metrics

Founded Year

1991

Location

Concord, United States

Stage

Public

Latest Funding Round

Grant (prize money), Feb 18, 2020, $*****

Investors

MidCap Financial & 5 more

Ranked

3^rd among 31 active competitors

Annual Revenue

$100M - $500M as on Dec 31, 2025

Employee Count

382 as on Sep 30, 2026

Similar Companies

Aethlon Medical & 33 more

Exit Details

Public

View Cerus' full profile

Cerus is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cerus Corp CIN: 1020214 , United States, Active		$100M - $500M (As on Dec 31, 2025)	-	-
Cerus Europe BV CIN: 0882.511.344 , Belgium, Active	Jul 13, 2006	-	-	-
CERUS LIMITED CIN: 11686201 , United Kingdom, Active	Nov 19, 2018	-	-
Cerus Corporation CIN: 680262011 , United States, Active	Dec 26, 999	-	227 (As on Dec 31, 2024)	-

Cerus got listed on Jan 30, 1997.

Click here to take a look at Cerus's IPO in detail

Cerus has raised funding over 6 rounds. Its first funding round was on May 18, 2001. Its latest funding round was a Grant (prize money) round on Feb 18, 2020 for $*****. 1 investor participated in its latest round. Cerus has 6 institutional investors.

Here is the list of recent funding rounds of Cerus:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 18, 2020	6168850	Grant (prize money)	1282932	7467745	2208744	1348174
Apr 01, 2019	7683405	Conventional Debt	5148842	8038424	8199497	MidCap Financial
Aug 11, 2011	4425280	Grant (prize money)	3278101	4770510	3433052	Military Health

Access funding benchmarks and valuations. Sign up today!

View details of Cerus's funding rounds and investors

Cerus' employee count trend

Cerus has 382 employees as of Sep 26. Here is Cerus's employee count trend over the years:

Uncover Cerus' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cerus include Aethlon Medical, Amferia and Cel-Sci. Here is the list of Top 10 competitors of Cerus, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aethlon Medical 1999, San Diego (United States), Public	Immunotherapeutic device company combating cancer and life-threatening viral infections	-	HHS, NIH	55/100
2nd	Amferia 2018, Gothenburg (Sweden), Series B	Developer of an anti-infective technology	$7.56M	Almi Invest, Chalmers Ventures & 5 others	55/100
3rd	Cerus 1991, Concord (United States), Public	Provider of pathogen inactivation technology for blood center or hospital blood bank	-	MidCap Financial, Apollo Investment Corporation ... & 4 others	61/100
4th	Cel-Sci 1983, Vienna (United States), Public	Developer of immunotherapy products for the treatment of cancer and infectious diseases	-	Alpha Capital Partners, Midsummer Capital ... & 7 others	53/100
5th	Ondine Biomedical 1999, Vancouver (Canada), Public	Developer of anti-infective therapies for a broad spectrum of bacterial, viral and fungal infections	$798K	Springboard Enterprises	49/100
6th	ARTCLINE 2007, Germany, Series A	Developer of immune cell-based extracorporeal therapies for intensive care medicine	$4.75M	-	47/100
7th	Z-App Kit 2007, Hafnarfjordur (Iceland), Unfunded	Developer of a amplifier and app for killing pathogenic microorganisms	-	-	45/100
8th	PATH EX 2016, Nashville (United States), Series A	Developing blood-cleansing device to remove pathogens from circulating blood	$5M	IAG Capital Partners, TMC Venture Fund & 9 others	39/100
9th	Larada Sciences 2006, Salt Lake City (United States), Series A	Leading head lice treatment clinics offering fast, safe, effective solutions	$4.46M	Tech Coast Angels, ventureCapital.org & 1 others	36/100
10th	ToeFX 2016, Hamilton (Canada), Seed	Company discovering and developing treatment of toenail fungus (onychomycosis)	$30K	Accelerator Centre, The Forge	35/100